Nureca Limited

Nureca Limited

Nureca Limited has resubmitted a more legible copy of its 10th Annual General Meeting (AGM) notice and Annual Report 2025-26 due to formatting issues.

Nureca Limited

Saurabh Goyal has submitted a disclosure under SEBI Takeover Regulations regarding an acquisition made in reliance on exemption provided in Regulation 10 of SEBI (SAST) Regulations, 2011.

Nureca Limited

Nureca Limited has informed the Exchange about the publication of a newspaper advertisement related to the 10th Annual General Meeting of the Company, including notice of book closure and E-Voting instructions.

Nureca Limited

Nureca Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 28, 2026

Nureca Limited

Nureca Limited has made a disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, regarding an off-market disposal of equity shares by a member of the Promoter Group.

Nureca Limited

Nureca Limited has made a disclosure under Regulation 7(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, regarding the off-market disposal of equity shares by a member of the Promoter Group through a Family Settlement Agreement.

Nureca Limited

Nureca Limited has made a disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, regarding an off-market acquisition of equity shares by a promoter through a family settlement agreement.

Nureca Limited

Nureca Limited has informed the Exchange about a copy of newspaper publication related to the 10th Annual General Meeting of the Company.

Nureca Limited

Nureca Limited has informed the Exchange about the resignation of a Director/KMP/SMP, but no further details are provided.

Nureca Limited

Nureca Limited has informed the Exchange about the resignation of a Director/KMP/SMP.

Nureca Limited

Nureca Limited has informed the Exchange regarding the cessation of Mr. Aryan Goyal as Whole-time Director & CEO of the company, effective July 1, 2026, due to a family settlement agreement.

Nureca Limited

Nureca Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Nureca Limited

Saurabh Goyal has submitted a disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, for Nureca Limited. This regulatory filing pertains to an acquisition of shares by a person acting in concert with the promoters or acquirer, which is exempt from an open offer. The announcement is a compliance update regarding changes in shareholding, likely involving related parties.

Nureca Limited

Nureca Limited announced a significant milestone for its "Dr Trust 360" platform, which has now crossed 2.4 million users. Alongside this user growth, the company has launched "Advanced AI Health Analytics" within the platform. This development highlights Nureca's expanding user base and its commitment to enhancing its health technology offerings with artificial intelligence. For investors, it indicates potential for increased engagement and a stronger competitive edge in the digital health sector.

Nureca Limited

Nureca Limited has informed the exchanges about a Family Settlement Agreement (FSA) executed on June 17, 2026, which involves certain members of its Promoter/Promoter Group. The company explicitly stated that it is not a party to this FSA. Furthermore, Nureca Limited has not independently verified the contents of the agreement, making this disclosure based solely on information furnished by the promoter group. This suggests the agreement is an internal matter among the promoters, with no direct operational or financial involvement from the company itself.